204 related articles for article (PubMed ID: 37601979)
1. Prognostic Role of Neutrophil to Lymphocyte Ratio in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Shavakhi M; Nourigheimasi S; Dioso E; Goutnik M; Lucke-Wold B; Khanzadeh S; Heidari F
Can J Gastroenterol Hepatol; 2022; 2022():1554079. PubMed ID: 37601979
[TBL] [Abstract][Full Text] [Related]
2. Predictive Role of Neutrophil-Percentage-to-Albumin Ratio (NPAR) in Nonalcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Nondiabetic US Adults: Evidence from NHANES 2017-2018.
Liu CF; Chien LW
Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111111
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil-to-lymphocyte ratio is independently associated with inflammatory activity and fibrosis grade in nonalcoholic fatty liver disease.
Khoury T; Mari A; Nseir W; Kadah A; Sbeit W; Mahamid M
Eur J Gastroenterol Hepatol; 2019 Sep; 31(9):1110-1115. PubMed ID: 30888972
[TBL] [Abstract][Full Text] [Related]
4. The role of neutrophil to lymphocyte ratio for the assessment of liver fibrosis and cirrhosis: a systematic review.
Peng Y; Li Y; He Y; Wei Q; Xie Q; Zhang L; Xia Y; Zhou X; Zhang L; Feng X; Chen K; Chen S; Chen W; Long Q; Chai J
Expert Rev Gastroenterol Hepatol; 2018 May; 12(5):503-513. PubMed ID: 29629626
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil-Lymphocyte Ratio (NLR) Could Be Better Predictor than C-reactive Protein (CRP) for Liver Fibrosis in Non-alcoholic Steatohepatitis(NASH).
Yilmaz H; Yalcin KS; Namuslu M; Celik HT; Sozen M; Inan O; Nadir I; Turkay C; Akcay A; Kosar A
Ann Clin Lab Sci; 2015; 45(3):278-86. PubMed ID: 26116591
[TBL] [Abstract][Full Text] [Related]
6. Towards an evaluation of alcoholic liver cirrhosis and nonalcoholic fatty liver disease patients with hematological scales.
Michalak A; Cichoż-Lach H; Guz M; Kozicka J; Cybulski M; Jeleniewicz W; Stepulak A
World J Gastroenterol; 2020 Dec; 26(47):7538-7549. PubMed ID: 33384553
[TBL] [Abstract][Full Text] [Related]
7. Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Taylor RS; Taylor RJ; Bayliss S; Hagström H; Nasr P; Schattenberg JM; Ishigami M; Toyoda H; Wai-Sun Wong V; Peleg N; Shlomai A; Sebastiani G; Seko Y; Bhala N; Younossi ZM; Anstee QM; McPherson S; Newsome PN
Gastroenterology; 2020 May; 158(6):1611-1625.e12. PubMed ID: 32027911
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of the role of neutrophil to lymphocyte ratio in neonatal sepsis.
Chen J; Yasrebinia S; Ghaedi A; Khanzadeh M; Quintin S; Dagra A; Peart R; Lucke-Wold B; Khanzadeh S
BMC Infect Dis; 2023 Nov; 23(1):837. PubMed ID: 38012554
[TBL] [Abstract][Full Text] [Related]
9. The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression.
Gudan A; Jamioł-Milc D; Hawryłkowicz V; Skonieczna-Żydecka K; Stachowska E
Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558421
[TBL] [Abstract][Full Text] [Related]
10. Association Between Neutrophil-to-Lymphocyte Ratio with Inflammatory Activity and Fibrosis in Non-alcoholic Fatty Liver Disease.
WenYi J; Ting Q; PiaoPiao Y; JinMing W
Turk J Gastroenterol; 2022 Jan; 33(1):53-61. PubMed ID: 35040788
[TBL] [Abstract][Full Text] [Related]
11. A novel model using mean platelet volume and neutrophil to lymphocyte ratio as a marker of nonalcoholic steatohepatitis in NAFLD patients: multicentric study.
Abdel-Razik A; Mousa N; Shabana W; Refaey M; ElMahdy Y; Elhelaly R; Elzehery R; Zalata K; Arafa M; Elbaz S; Hafez M; Awad M
Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):e1-9. PubMed ID: 26469357
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio as prognostic predictors for delirium in critically ill patients: a systematic review and meta-analysis.
Sarejloo S; Shojaei N; Lucke-Wold B; Zelmanovich R; Khanzadeh S
BMC Anesthesiol; 2023 Feb; 23(1):58. PubMed ID: 36803215
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil-to-lymphocyte ratio is not a predictor of liver histology in patients with nonalcoholic fatty liver disease.
Kara M; Dogru T; Genc H; Sertoglu E; Celebi G; Gurel H; Kayadibi H; Cicek AF; Ercin CN; Sonmez A
Eur J Gastroenterol Hepatol; 2015 Oct; 27(10):1144-8. PubMed ID: 26062078
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil to Lymphocyte Ratio and Spontaneous Bacterial Peritonitis among Cirrhotic Patients: A Systematic Review and Meta-analysis.
Seyedi SA; Nabipoorashrafi SA; Hernandez J; Nguyen A; Lucke-Wold B; Nourigheimasi S; Khanzadeh S
Can J Gastroenterol Hepatol; 2022; 2022():8604060. PubMed ID: 36204262
[TBL] [Abstract][Full Text] [Related]
15. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies.
Singh S; Allen AM; Wang Z; Prokop LJ; Murad MH; Loomba R
Clin Gastroenterol Hepatol; 2015 Apr; 13(4):643-54.e1-9; quiz e39-40. PubMed ID: 24768810
[TBL] [Abstract][Full Text] [Related]
16. Clinical value of thyroid related hormones combined with neutrophil to lymphocyte ratio in patients with nonalcoholic fatty liver disease.
Li P; Liu L; Niu B; Mi Y; Liu Y; Feng J; Zhang P; Wu X; Chu W
Medicine (Baltimore); 2022 Dec; 101(51):e31978. PubMed ID: 36595785
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease.
Alkhouri N; Morris-Stiff G; Campbell C; Lopez R; Tamimi TA; Yerian L; Zein NN; Feldstein AE
Liver Int; 2012 Feb; 32(2):297-302. PubMed ID: 22097893
[TBL] [Abstract][Full Text] [Related]
18. Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis.
Balakrishnan M; Patel P; Dunn-Valadez S; Dao C; Khan V; Ali H; El-Serag L; Hernaez R; Sisson A; Thrift AP; Liu Y; El-Serag HB; Kanwal F
Clin Gastroenterol Hepatol; 2021 Jan; 19(1):61-71.e15. PubMed ID: 32360810
[TBL] [Abstract][Full Text] [Related]
19. Role of diabetologists in the management of nonalcoholic fatty liver disease: Primary prevention and screening/management of fibrosis and cirrhosis.
Kuchay MS; Misra A
Diabetes Metab Syndr; 2022 Mar; 16(3):102446. PubMed ID: 35259705
[TBL] [Abstract][Full Text] [Related]
20. Circulating leptin in patients with nonalcoholic fatty liver disease-related liver fibrosis: a systematic review and a meta-analysis.
Makri ES; Evripidou K; Polyzos SA
J Gastroenterol Hepatol; 2024 May; 39(5):806-817. PubMed ID: 38238084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
